Examkin

Question

Difficulty: MediumInterpreting Laboratory Results

A 6262-year-old woman with a 1515-year history of type 2 diabetes mellitus and hypertension presents to the clinic for a routine follow-up examination. She has no new complaints. Her medications include insulin glargine and amlodipine. Vital signs show a blood pressure of 142/88 mmHg142/88 \text{ mmHg} and a heart rate of 76/min76/\text{min}. Laboratory studies are obtained and reveal the following:

Laboratory TestResultReference Range
Sodium138 mEq/L138 \text{ mEq/L}136−145 mEq/L136-145 \text{ mEq/L}
Potassium5.7 mEq/L5.7 \text{ mEq/L}3.5−5.0 mEq/L3.5-5.0 \text{ mEq/L}
Chloride110 mEq/L110 \text{ mEq/L}95−105 mEq/L95-105 \text{ mEq/L}
Bicarbonate18 mEq/L18 \text{ mEq/L}22−28 mEq/L22-28 \text{ mEq/L}
Blood urea nitrogen34 mg/dL34 \text{ mg/dL}8−20 mg/dL8-20 \text{ mg/dL}
Creatinine1.8 mg/dL1.8 \text{ mg/dL}0.6−1.2 mg/dL0.6-1.2 \text{ mg/dL}
Glucose (fasting)162 mg/dL162 \text{ mg/dL}70−110 mg/dL70-110 \text{ mg/dL}

Urinalysis is positive for microalbuminuria. The urine pH is 5.25.2. Which of the following is the most likely underlying mechanism for this patient's current electrolyte and acid-base findings?

  1. Decreased production of and responsiveness to aldosteroneAnswer
  2. B
    Impaired distal tubular secretion of hydrogen ions
  3. C
    Defective proximal tubular reabsorption of bicarbonate
  4. D
    Excessive gastrointestinal loss of bicarbonate-rich fluids
  5. E
    Accumulation of unmeasured endogenous organic acids

Answer

Decreased production of and responsiveness to aldosterone
The correct answer accurately describes the pathophysiology of Type 4 renal tubular acidosis (RTA). This patient presents with a non-anion gap metabolic acidosis (NAGMA), as evidenced by a calculated serum anion gap of 10 mEq/L10 \text{ mEq/L}. When evaluating a NAGMA, the serum potassium is a critical distinguishing factor. This patient's hyperkalemia (5.7 mEq/L5.7 \text{ mEq/L}) strongly suggests Type 4 RTA, also known as hyporeninemic hypoaldosteronism. This condition is classically seen in patients with long-standing diabetes mellitus and mild-to-moderate chronic kidney disease (diabetic nephropathy). Damage to the juxtaglomerular apparatus decreases renin production, leading to decreased aldosterone levels and diminished responsiveness to aldosterone in the distal nephron. This results in impaired potassium and hydrogen ion excretion, leading to hyperkalemia and a mild metabolic acidosis. Because the primary defect is in aldosterone action rather than the distal tubule's intrinsic ability to acidify urine, the urine pH remains acidic (<5.5< 5.5).

Step-by-Step Solution

1
Calculate the serum anion gap to classify the metabolic acidosis.
Anion Gap=Na+−(Cl−+HCO3−)=138−(110+18)=10 mEq/L\text{Anion Gap} = \text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-) = 138 - (110 + 18) = 10 \text{ mEq/L}.
Determining whether an acidosis is 'anion gap' or 'non-anion gap' is the first step in narrowing the differential diagnosis.
2
Evaluate the potassium level and urine pH in the context of a non-anion gap metabolic acidosis (NAGMA).
The patient has hyperkalemia (5.7 mEq/L5.7 \text{ mEq/L}) and acidic urine (pH=5.2\text{pH} = 5.2).
Potassium levels and urine pH differentiate the etiologies of NAGMA, particularly the subtypes of renal tubular acidosis (RTA) and gastrointestinal losses.
3
Correlate the lab findings with the patient's clinical history.
The combination of NAGMA, hyperkalemia, acidic urine, and diabetic nephropathy points directly to Type 4 RTA (hyporeninemic hypoaldosteronism).
Type 4 RTA is classically seen in patients with mild-to-moderate chronic kidney disease, particularly due to diabetic nephropathy, which impairs renin release and downstream aldosterone action.

Key Concept

Interpretation of non-anion gap metabolic acidosis with hyperkalemia (Type 4 Renal Tubular Acidosis)
Estimated Time:1m 30s
Rate this question

Topics

Interpreting Laboratory Results

More questions from this topic